Imax Corp (NYSE: IMAX) open the trading on Thursday, with great promise as it jumped 3.51% to $36.3, before settling in for the price of $35.07 at the close. Taking a more long-term approach, IMAX posted a 52-week range of $20.48-$39.98.
The company of the Communication Services sector’s yearbook sales growth during the past 5- year span was recorded -8.74%. Meanwhile, its Annual Earning per share during the time was -8.74%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 40.95%. This publicly-traded company’s shares outstanding now amounts to $53.80 million, simultaneously with a float of $43.32 million. The organization now has a market capitalization sitting at $1.95 billion.
Imax Corp (IMAX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Entertainment industry. Imax Corp’s current insider ownership accounts for 19.48%, in contrast to 92.79% institutional ownership. Preceding that transaction, on Dec 15 ’25, Company’s President IMAX Global Theatres sold 25,000 for 39.28, making the whole transaction’s value amount to 982,000. This particular insider is now the holder of 128,323 in total.
Imax Corp (IMAX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.27 per share during the current fiscal year.
Imax Corp’s EPS increase for this current 12-month fiscal period is 40.95% and is forecasted to reach 1.62 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 24.98% through the next 5 years, which can be compared against the -8.74% growth it accomplished over the previous five years trading on the market.
Imax Corp (NYSE: IMAX) Trading Performance Indicators
Let’s observe the current performance indicators for Imax Corp (IMAX). It’s Quick Ratio in the last reported quarter now stands at 1.61. Alongside those numbers, its PE Ratio stands at $50.76, and its Beta score is 0.38. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.17. Similarly, its price to free cash flow for trailing twelve months is now 19.90.
In the same vein, IMAX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.72, a figure that is expected to reach 0.46 in the next quarter, and analysts are predicting that it will be 1.62 at the market close of one year from today.
